Skip to content
TrialScanner

NCT03203369

Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN

Phase 1TerminatedCLLSLead

Registry record

Lead sponsor
Cellectis S.A.
Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Primary completion
Jun 27, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03203369 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03203369: Study to Evaluate the Safety... | TrialScanner